Compare PPCB & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PPCB | ULY |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 4.8M |
| IPO Year | N/A | N/A |
| Metric | PPCB | ULY |
|---|---|---|
| Price | $0.22 | $2.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 565.5K | ★ 1.1M |
| Earning Date | 02-15-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $127,932,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $1.74 |
| 52 Week High | $145.46 | $17.99 |
| Indicator | PPCB | ULY |
|---|---|---|
| Relative Strength Index (RSI) | 27.01 | 41.59 |
| Support Level | $0.24 | $2.16 |
| Resistance Level | $0.40 | $2.50 |
| Average True Range (ATR) | 0.06 | 0.23 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 7.08 | 4.25 |
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.